Morning Buzz: PlasmaTech (PTBI), IsoRay, Inc. (ISR), Genocea Biosciences (GNCA), Yahoo (YHOO)

Shares of PlasmaTech Biopharmaceuticals, Inc. (PTBI) are higher by nearly 9% to $10.34 in premarket trading on Wednesday after the company announced that the U.S. Food and Drug Administration had granted both Orphan Drug Designation and Rare Pediatric Disease Designation for both of PlasmaTech’s lead product candidates for the treatment of Sanfilippo Syndromes A and […] View the full post at: Morning Buzz: PlasmaTech (PTBI), IsoRay, Inc. (ISR), Genocea Biosciences (GNCA), Yahoo (YHOO) Related posts: Experimental Prostate-Cancer Drug Shows Promise Yahoo Buzz Now Open To Everyone US panel rejects Forest, Nycomed lung drug
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.